NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Is Drug Coverage a Free Lunch? Cross-Price Elasticities and the Design of Prescription Drug Benefits

Martin Gaynor, Jian Li, William B. Vogt

NBER Working Paper No. 12758
Issued in December 2006
NBER Program(s):   HC

Recently, many U.S. employers have adopted less generous prescription drug benefits. In addition, the U.S. began to offer prescription drug insurance to approximately 42 million Medicare beneficiaries in 2006. We use data on individual health insurance claims and benefit data from 1997-2003 to study the effects of changing consumers' co-payments for prescription drugs on the quantity demanded and expenditure on prescription drugs, inpatient care and outpatient care. We allow for effects both in the year of the co-payment change and in the year following the change. Our results show that increases in prescription drug prices reduce both the use of and spending on prescription drugs. However, consumers substitute the use of outpatient care and inpatient care for prescription drug use, and about 35% of the expenditure reductions on prescription drugs are offset by the increases in other spending.

download in pdf format
   (224 K)

email paper

A non-technical summary of this paper is available in the June 2007 NBER digest.  You can sign up to receive the NBER Digest by email.

The NBER Bulletin on Aging and Health provides summaries of publications like this.  You can sign up to receive the NBER Bulletin on Aging and Health by email.

This paper is available as PDF (224 K) or via email.

This paper was revised on May 14, 2007

Machine-readable bibliographic record - MARC, RIS, BibTeX

Document Object Identifier (DOI): 10.3386/w12758

Users who downloaded this paper also downloaded these:
Crown, Berndt, Baser, Finkelstein, and Witt w10062 Benefit Plan Design and Prescription Drug Utilization Among Asthmatics: Do Patient Copayments Matter?
Cutler and Zeckhauser w7176 The Anatomy of Health Insurance
Dor and Encinosa w10738 How Does Cost-Sharing Affect Drug Purchases? Insurance Regimes in the Private Market for Prescription Drugs
Chandra, Gruber, and McKnight w12972 Patient Cost-Sharing, Hospitalization Offsets, and the Design of Optimal Health Insurance for the Elderly
Heiss, McFadden, and Winter w13627 Mind the Gap! Consumer Perceptions and Choices of Medicare Part D Prescription Drug Plans
 
Publications
Activities
Meetings
NBER Videos
Data
People
About

Support
National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us